top of page
  • Facebook
  • YouTube
  • Instagram
Staar Homepage Banner.jpg
STAAR Medallion Home Page-01.png
Leading the Fight Against
Low-Grade Serous Ovarian Cancer

THE FIRST US FOUNDATION DEDICATED TO FUNDING LGSOC RESEARCH

Why STAAR?

STAAR stands for SURVIVE. THRIVE. ADVOCATE. ADVANCE RESEARCH.​

STAAR Low-Grade Serous Ovarian Cancer was founded in 2020 when three women facing low-grade serous ovarian cancer recognized the urgent need for dedicated funding and support—a need unmet by the larger charities.​​

 

​The foundation exists to fund research for better treatment options for low-grade serous carcinoma, a rare (about 5% of ovarian cancer cases) and extremely underfunded ovarian cancer.

We fund research to provide better outcomes for people with LGSOC. 

We support the LGSOC community with resources and a place to connect.

100% volunteer-run means more of every dollar goes directly to our mission.

STAAR is the first U.S. charity focused on funding LGSOC research.

LGSOC Disproportionately Affects Younger Women

​Today.com recently featured a story about STAAR board member Emma Schlamm, who first experienced symptoms of LGSOC when she was 25. Read her story here.

Stomach Ache

Not Feeling 100%? Don't Ignore It!

Persistent symptoms need attention. Our symptom checker is a simple tool to help you identify common signs of low-grade serous ovarian cancer. If your symptoms persist for more than two weeks, it's time to speak with your doctor.

Lab Grown Meat_edited.jpg

Advancing Research

To Improve Outcomes for LGSOC

Low-grade serous ovarian cancer (LGSOC) is a rare and understudied disease, leaving patients with limited treatment options. STAAR Low-Grade Serous Ovarian Cancer Foundation is the first U.S. nonprofit solely dedicated to funding LGSOC research.We work directly with leading scientists, research institutions, and medical experts to:

​

  • Fund groundbreaking studies that explore new treatment approaches

  • Drive collaboration between researchers and clinicians for faster discoveries

  • Advocate for increased investment in LGSOC research

 

Although LGSOC is a distinct and understudied form of ovarian cancer, it receives only a fraction of the research funding needed to develop life-saving treatments. STAAR is changing that by prioritizing research grants that directly impact patient survival and quality of life.

 

Our Partnership with the Low-Grade Serous Ovarian Cancer Initiative

LGSOC Initiative.png

Formerly known as Cure Our Ovarian Cancer, the Low-Grade Serous Ovarian Cancer Initiative was founded in New Zealand in 2018, blazing a trail as the world's first nonprofit dedicated to low-grade serous ovarian cancer (LGSOC).

Through our partnership, we amplify our impact—funding groundbreaking research and providing vital resources to those affected by LGSOC. Together, we’re building a stronger community, sharing knowledge, and fostering hope.

Despite LGSOC being rare but life-altering, research funding remains extremely limited. STAAR is working to change that by funding critical studies that lead to better treatments and improved outcomes.

 

bottom of page